HT-4403

N/A

Report date: 2024/01/09 10:48:25
NME

Base Information

Drug NameHT-4403
Drug Alias NameHT-4403
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 inhibitors
TargetsLeucine-rich repeat serine/threonine-protein kinase 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesHalia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHalia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A